Polyglutamine diseases: looking beyond the neurodegenerative universe.
Neural Regen Res, 2021 Mielcarek M, Isalan M.
europepmc +1 more source
Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases
, 2020 Feng Ding +3 more
openalex +1 more source
Inhibition of Autophagy via p53-Mediated Disruption of ULK1 in a SCA7 Polyglutamine Disease Model
, 2013 Xin Yu +6 more
openalex +2 more sources
Recruitment of Nonexpanded Polyglutamine Proteins to Intranuclear Aggregates in Neuronal Intranuclear Hyaline Inclusion Disease [PDF]
, 2001 Junko Takahashi +7 more
openalex +1 more source
Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases. [PDF]
Cell Mol Life Sci, 2020 Davis AK +3 more
europepmc +1 more source
Polyglutamine Expansion in Huntingtin and Mechanism of DNA Damage Repair Defects in Huntington’s Disease [PDF]
, 2022 Subrata Pradhan +5 more
openalex +1 more source
Selective silencing of expanded CAG repeats: Chemically modified siRNA advances RNA-based therapies for polyglutamine diseases. [PDF]
Mol Ther Nucleic AcidsScholten GJ, Hyde JT, Buijsen RAM.
europepmc +1 more source
Disease Progression Despite Early Loss of Polyglutamine Protein Expression in SCA7 Mouse Model [PDF]
, 2004 Dominique Helmlinger +7 more
openalex +1 more source
Challenges in Polyglutamine Diseases: From Dysfunctional Neuronal Circuitries to Neuron-Specific CAG Repeat Instability. [PDF]
Int J Mol SciDeleanu R.
europepmc +1 more source